2b Opioids in chronic pain

Arner, 1988, Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain, Pain, 33, 11, 10.1016/0304-3959(88)90198-4 Berger, 1996, Controlled-release oral morphine (MS Contin110 tablets) versus fentanyl transdermal system (Duragesic110) for the outpatient treatment, 21 Berger, 1996, Controlled-release oral morphine (MS Contin110 tablets) versus fentanyl transdermal system (Duragesic110) for the outpatient treatment, A61 Bonica, 1985, Treatment of cancer pain: current status and future needs, vol. 9, 589 Boureau, 1992, A comparative study of controlled-release morphine (CRM) suspension and CRM tablets in chronic cancer pain, Journal of Pain and Symptom Management, 7, 393, 10.1016/0885-3924(92)90018-D Bruera, 1987, Continous sc infusion of narcotics using a portable dispensable device in patients with advanced cancer, Cancer Treatment Reports, 71, 635 Bruera, 1988, Patient-controlled subcutaneous hydromorphone versus continuous subcutaneous infusion for the treatment of cancer pain, Journal of the National Cancer Institute, 80, 1152, 10.1093/jnci/80.14.1152 Bruera, 1988, Use of the subcutaneous route for the administration of narcotics in patients with cancer pain, Cancer, 62, 407, 10.1002/1097-0142(19880715)62:2<407::AID-CNCR2820620227>3.0.CO;2-T Bruera, 1995, Steady-state pharmacokinetic evaluation of a novel, controlled-release morphine suppository and subcutaneous morphine in cancer pain, Journal of Clinical Pharmacology, 35, 666, 10.1002/j.1552-4604.1995.tb04106.x Bruera, 1995, Clinical efficacy and safety of a novel controlled-release morphine suppository and subcutaneous morphine in cancer pain: a randomized evaluation, Journal of Clinical Oncology, 13, 1520, 10.1200/JCO.1995.13.6.1520 Bruera, 1995, Custom-made capsules and suppositories of methadone for patients on high-dose opioids for cancer pain, Pain, 62, 141, 10.1016/0304-3959(94)00257-F Bruera, 1996, A randomized, double-blind, double-dummy, crossover trial comparing the safety and efficacy of oral sustained-release hydromorphone with immediate-release hydromorphone in patients with cancer pain, Journal of Clinical Oncology, 14, 1713, 10.1200/JCO.1996.14.5.1713 De Conno, 1991, A clinical study on the use of codeine, oxycodone, dextropropoxyphene, buprenorphine, and pentazocine in cancer pain, Journal of Pain and Symptom Management, 6, 423, 10.1016/0885-3924(91)90040-B De Conno, 1995, Role of rectal route in treating cancer pain: a randomized crossover clinical trial of oral versus rectal morphine administration in opioid-naive cancer patients with pain, Journal of Clinical Oncology, 13, 1004, 10.1200/JCO.1995.13.4.1004 Cundiff, 1989, Evaluation of a cancer pain model for the testing of long-acting analgesics. The effect of MS Contin in a double-blind, randomized crossover design, Cancer, 63, S2355, 10.1002/1097-0142(19890601)63:11<2355::AID-CNCR2820631147>3.0.CO;2-# Dellemijn, 1997, Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain, Lancet, 49, 753, 10.1016/S0140-6736(96)09024-1 Dertwinkel, 1996, Orale Opioide zur, Langzeittherapie chronischer Nicht-Tumorschmerzen, Anaesthesist, 45, 495, 10.1007/s001010050282 Deschamps, 1992, The evaluation of analgesic effects in cancer patients as exemplified by a double-blind, crossover study of immediate-release versus controlled-release morphine, Journal of Pain and Symptom Management, 7, 384, 10.1016/0885-3924(92)90017-C Donner, 1996, Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain, Pain, 64, 527, 10.1016/0304-3959(95)00180-8 Drexel, 1989, Treatment of severe cancer pain by low dose continuous subcutaneous morphine, Pain, 36, 169, 10.1016/0304-3959(89)90020-1 Ferrell, 1989, Effects of controlled-release morphine on quality of life for cancer pain, Oncology Nursing Forum, 16, 521 Ferrer-Brechner, 1984, Combination therapy with ibuprofen and methadone for chronic cancer pain, American Journal of Medicine, 13, 78, 10.1016/S0002-9343(84)80023-6 Finn, 1993, Placebo-blinded study of morphine sulfate sustained-release tablets and immediate-release morphine sulfate solution in outpatients with chronic pain due to advanced cancer, Journal of Clinical Oncology, 11, 967, 10.1200/JCO.1993.11.5.967 France, 1984, Long-term use of narcotic analgesics in chronic pain, Social Science and Medicine, 19, 1379, 10.1016/0277-9536(84)90027-3 Goughnour, 1989, Analgesic response to single and multiple doses of controlled-release morphine tablets and morphine oral solution in cancer patients, Cancer, 63, S2294, 10.1002/1097-0142(19890601)63:11<2294::AID-CNCR2820631139>3.0.CO;2-X Gourlay, 1986, A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer, Pain, 25, 297, 10.1016/0304-3959(86)90234-4 Gralow, 1990, Kontinuierliche subkutane Morphingabe mittels eines externen tragbaren Infusorsystems bei inkurablen Kopf-Hals-Tumoren: Pilotstudie, European Journal of Pain, 11, 147 Grochow, 1989, Does intravenous methadone provide longer lasting analgesia than intravenous morphine? A randomized, double-blind study, Pain, 38, 151, 10.1016/0304-3959(89)90233-9 Grond, 1997, Transdermal fentanyl in the long-term treatment of cancer pain: a prospective study of 50 patients with advanced cancer of the gastrointestinal tract or the head and neck region, Pain, 69, 191, 10.1016/S0304-3959(96)03254-X Hanks, 1987, Controlled release morphine tablets: a double-blind trial in patients with advanced cancer, Anaesthesia, 42, 840, 10.1111/j.1365-2044.1987.tb04107.x Hays, 1994, Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain, Cancer, 74, 1808, 10.1002/1097-0142(19940915)74:6<1808::AID-CNCR2820740625>3.0.CO;2-Y Herbst, 1992, Transdermal fentanyl use in hospice home-care patients with chronic cancer pain, Journal of Pain and Symptom Management, 7, S54, 10.1016/0885-3924(92)90056-N Homesley, 1986, Dosage range study of morphine sulfate controlled-release, American Journal of Clinical Oncology, 9, 449, 10.1097/00000421-198610000-00018 Jadad, 1995, The WHO analgesic ladder for cancer pain management, Journal of the American Medical Association, 274, 1870, 10.1001/jama.1995.03530230056031 Jadad, 1992, Morphine responsiveness of chronic pain: double-blind randomised crossover study with patient controlled analgesia, Lancet, 339, 1367, 10.1016/0140-6736(92)91194-D Kaiko, 1989, The United States experience with oral controlled-release morphine (MS Contin tablets). Parts I and II. Review of nine dose titration studies and clinical pharmacology of 15-mg, 30-mg, 60-mg, and 100-mg tablet strengths in normal subjects, Cancer, 63, S2348, 10.1002/1097-0142(19890601)63:11<2348::AID-CNCR2820631146>3.0.CO;2-V Kerr, 1988, Continous narcotic infusions with patient-controlled analgesia for chronic cancer pain in outpatients, Annals of Internal Medicine, 108, 554, 10.7326/0003-4819-108-4-554 Khojasteh, 1987, Controlled-release oral morphine sulfate in the treatment of cancer pain with pharmacokinetic correlation, Journal of Clinical Oncology, 5, 956, 10.1200/JCO.1987.5.6.956 Kim, 1991, Experience with a controlled-release oral morphine for cancer pain management, Postgraduate Medical Journal, 67, S82 Korte, 1994, Transdermal fentanyl in uncontrolled cancer pain: titration on a day-to-day basis as a procedure for safe and effective dose finding—a pilot study in 20 patients, Support Care Cancer, 2, 123, 10.1007/BF00572094 Korte, 1996, Day-to-day titration to initiate transdermal fentanyl in patients with cancer pain: short- and long-term experiences in a prospective study of 39 patients, Journal of Pain and Symptom Management, 11, 139, 10.1016/0885-3924(95)00162-X Kossmann, 1985, Therapie von Karzinomschmerzen—Vergleich einer wässrigen Morphinlösung mit MST-Tabletten, Schmerz, 4, 143 Lapin, 1989, Cancer pain management with a controlled-release oral morphine preparation, Journal of Pain and Symptom Management, 4, 146, 10.1016/0885-3924(89)90008-0 Lazarus, 1990, A multi-investigator clinical evaluation of oral controlled-release morphine (MS Contin® tablets) administered to cancer patients, Hospice Journal, 6, 1, 10.1300/J011v06n04_01 Levy, 1992, Transdermal fentanyl: seeding trial in patients with chronic cancer pain, Journal of Pain and Symptom Management, 7, S48, 10.1016/0885-3924(92)90054-L McQuay, 1992, Opioid sensitivity of chronic pain: a patient-controlled analgesia method, Anaesthesia, 47, 757, 10.1111/j.1365-2044.1992.tb03253.x Maves, 1992, Management of cancer pain with transdermal fentanyl: phase IV trial, University of lowa, Journal of Pain and Symptom Management, 7, S58, 10.1016/0885-3924(92)90057-O Mignault, 1995, Control of cancer-related pain with MS Contin: a comparison between 12-hourly and 8-hourly administration, Journal of Pain and Symptom Management, 10, 416, 10.1016/0885-3924(95)00063-5 Miser, 1987, Continous intravenous Fentanyl for pain control in children and young adults with cancer, Clinical Journal of Pain, 3, 152, 10.1097/00002508-198703000-00006 Miser, 1986, Prospective study of continous intravenous and subcutaneous morphine infusions for therapy-related or cancer-related pain in children and young adults with cancer, Clinical Journal of Pain, 2, 101, 10.1097/00002508-198602020-00005 Miser, 1989, Transdermal fentanyl for pain control in patients with cancer, Pain, 37, 15, 10.1016/0304-3959(89)90148-6 Moran, 1991, MST continus tablets and pain control in severe rheumatoid arthritis, British Journal of Clinical Research, 2, 1 Moulin, 1996, A clinical evaluation of TTS-fentanyl for the treatment of cancer pain, 22 Moulin, 1996, A clinical evaluation of TTS-fentanyl for the treatment of cancer pain, A 63 Moulin, 1991, Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain, Clinical Practice, 337, 465 Moulin, 1992, Subcutaneous narcotic infusions for cancer pain: treatment outcome and guidelines for use, Canadian Medical Association Journal, 146, 891 Moulin, 1996, Randomised trial of oral morphine for chronic non-cancer pain, Lancet, 347, 143, 10.1016/S0140-6736(96)90339-6 Noda, 1989, Continuous subcutaneous infusion of buprenorphine for cancer pain control, Clinical Journal of Pain, 5, 147, 10.1097/00002508-198906000-00004 Panich, 1993, Comparison of morphine slow release tablet (MST) and morphine sulphate solution (MSS) in the treatment of cancer pain, Journal of the Medical Association of Thailand, 76, 672 Papagallo, 1994, Chronic opioid therapy as alternative treatment for post-herpetic neuralgia, Annals of Neurology, 35, 54, 10.1002/ana.410350716 Portenoy, 1986, Chronic use of opioid analgesics in non malignant pain: report of 38 cases, Pain, 25, 171, 10.1016/0304-3959(86)90091-6 Portenoy, 1986, IV infusion of opioids for cancer pain: clinical review and guidelines for use, Cancer Treatment Reports, 70, 575 Portenoy, 1989, Oral controlled-release morphine sulfate. Analgesic efficacy and side effects of a 100-mg tablet in cancer pain patients, Cancer, 63, S2284, 10.1002/1097-0142(19890601)63:11<2284::AID-CNCR2820631137>3.0.CO;2-3 Ripamonti, 1995, Rectal methadone in cancer patients with pain, Annals of Oncology, 6, 841, 10.1093/oxfordjournals.annonc.a059327 Rowbotham, 1991, Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia, Neurology, 41, 1024, 10.1212/WNL.41.7.1024 Schofferman, 1993, Long-term use of opioid analgesics for the treatment of chronic pain of non-malignant origin, Journal of Pain and Symptom Management, 8, 279, 10.1016/0885-3924(93)90156-P Schoon, 1987, Die kontinuierliche subkutane opioidinfusion in der onkologischen Schmerztherapie, Medizinische Klinik, 82, 805 Schulzeck, 1993, Morphintabletten bei chronischen nicht tumorbedingten Schmerzen, Anaesthesist, 42, 545 Simmonds, 1989, TTS (fentanyl) in the management of pain in patients with cancer, 8, 234 Sittl, 1991, Tumorschmerztherapie bei Kindern und Jugendlichen mit Morphin, Anaesthesist, 40, 96 Slover, 1992, Transdermal fentanyl: clinical trial at the University of Colorado Health Sciences Center, Journal of Pain and Symptom Management, 7, S45, 10.1016/0885-3924(92)90053-K Sorge, 1991, Opioidanalgetika bei ‘nichtmalignen’ Schmerzen—Langzeitbehandlungsergebnisse bei Patienten mit rheumatischen Beschwerden, Schmerz, 5, 60, 10.1007/BF02529469 Sorge, 1990, Long-term therapy of tumor pain using morphine-retard tablets, Medizinische Klinik, 85, 523 Strumpf, 1995, Morphin-Retardgranulat zur Therapie inkurabler Schmerzen tumorbedingter und nicht-tumorbedingter Genese—Pilotstudie, Schmerz, 9, 140, 10.1007/BF02530132 Stuart, 1986, Continuous intravenous morphine infusions for terminal pain control: a retrospective review, Drug Intelligence and Clinical Pharmacy, 20, 968, 10.1177/106002808602001211 Swanson, 1989, Patient-controlled analgesia for chronic cancer pain in the ambulatory setting: a report of 117 patients, Journal of Clinical Oncology, 7, 1903, 10.1200/JCO.1989.7.12.1903 Taub, 1982, Opioid analgesics in the treatment of chronic intractable pain of non neoplastic origin Tennant, 1988, Chronic opioid treatment on intractable, non-malignant pain, NIDA Research Monographs, 81, 357 Tsuneto, 1991, A clinical survey of controlled-release morphine sulphate for cancer pain relief in a Japanese hospice, Postgraduate Medical Journal, 67, S79 1994, Transdermal fentanyl in cancer patients, Journal of Drug Development, 6, 93 Urban, 1986, Longterm use of narcotic/antidepressant medication in the management of phantom limb pain, Pain, 24, 191, 10.1016/0304-3959(86)90041-2 Vanier, 1993, Comparison of hydromorphone continuous subcutaneous infusion and basal rate subcutaneous infusion plus PCA in cancer pain: a pilot study, Pain, 53, 27, 10.1016/0304-3959(93)90051-P Ventafridda, 1986, A randomized study on oral administration of morphine and methadone in the treatment of cancer pain, Journal of Pain and Symptom Management, 1, 203, 10.1016/S0885-3924(86)80042-2 Ventafridda, 1987, A validation study of the WHO method for cancer pain relief, Cancer, 59, 850, 10.1002/1097-0142(19870215)59:4<850::AID-CNCR2820590432>3.0.CO;2-1 Ventafridda, 1989, Clinical observations on controlled-release morphine in cancer pain, Journal of Pain and Symptom Management, 4, 124, 10.1016/0885-3924(89)90005-5 Walker, 1988, Evaluation of WHO analgesic guidelines for cancer pain in a hospital-based palliative care unit, Journal of Pain and Symptom Management, 3, 145, 10.1016/0885-3924(88)90160-1 Walsh, 1993, A controlled study of sustained-release morphine sulfate tablets in chronic pain from advanced cancer, American Journal of Clinical Oncology, 15, 268, 10.1097/00000421-199206000-00018 Watanabe, 1996, Capsules and suppositories of methadone for patients on high-dose opioids for cancer pain: clinical and economic considerations, Cancer Treatment Review, 22, S131, 10.1016/S0305-7372(96)90075-4 Zech, 1995, Transdermal fentanyl in combination with initial intravenous dose titration by patient-controlled analgesia, Anti Cancer Drugs, 6, S35, 10.1097/00001813-199504003-00008 Zech, 1992, Transdermal fentanyl and initial dose-finding with patient-controlled analgesia in cancer pain. A pilot study with 20 terminally ill cancer patients, Pain, 50, 293, 10.1016/0304-3959(92)90034-9 Zech, 1995, Validation of World Health Organisation guidelines for cancer pain relief: a 10-year prospective study, Pain, 63, 65, 10.1016/0304-3959(95)00017-M Zenz, 1992, Long-term opioid therapy in patients with chronic non-malignant pain, Journal of Pain and Symptom Management, 7, 69, 10.1016/0885-3924(92)90116-Y Zenz, 1985, Langzeittherapie von Krebsschmerzen. Kontrollierte Studie mit Buprenorphin, Deutsche Medizinische Wochenschrift, 110, 448, 10.1055/s-2008-1068844 Zenz, 1989, Retardiertes Morphin zur Langzeittherapie schwerer Tumorschmerzen, Deutsche Medizinische Wochenschrift, 114, 43, 10.1055/s-2008-1066549